Activation of the FGF2/FGFR autocrine loop in IM-treated GISTs was also revealed by in vivo studies illustrating nuclear localization of FGF-2 in GIST xenografts after IM treatment (Figure 6D) and tumor specimens of GIST patients who received IM-based therapy (Figure 7A). Here, FGF2 is linked to neoplasm.